NCT07453394 2026-03-06QLS5132 Combination Therapy in Advanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting626 enrolled
NCT07045805 2025-07-01Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric CancerThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 2 Not yet recruiting66 enrolled